Mr. Robert F. Williamson III

• 
  www.sec.gov/Archives/edgar/data/1397331/0001192482-08-0 - [Cached Version]
  Published on: 9/26/2008    Last Visited: 9/27/2008  

  0001397331 Williamson Robert F III 303A COLLEGE ROAD EAST PRINCETON NJ 08540 1 0 0 0

• 
  www.getwilliams.com/article.cfm/id/245835 - [Cached Version]
  Published on: 10/13/2008    Last Visited: 1/22/2008  

  Dr. Williamson had served as associate dean for the online university.

• 
  www.allinmag.com/article.php?article=710 - [Cached Version]
  Published on: 10/5/2006    Last Visited: 12/30/2007  

  Contributing writers include poker superstars Chris "Jesus" Ferguson, Howard Lederer, Robert Williamson III, Phil Gordon, and others, as well as an

• 
  wwww.casino-poker-rules.com/Kasey-Thompson-Becomes-Sole - [Cached Version]
  Published on: 9/14/2006    Last Visited: 1/19/2008  

  Contributing writers include poker superstars Chris "Jesus" Ferguson, Howard Lederer, Robert Williamson III, Phil Gordon, and others, as well as an assortment of award-winning journalists and authors.

• 
  www.getwilliams.com/ - [Cached Version]
  Published on: 12/21/2006    Last Visited: 1/22/2008  

  Dr. Williamson had served as associate dean for the online university.
  ...
  Dr. Williamson had served as associate dean for the online university.

• 
  www.pokernewstoday.com/fullnews/2263/ - [Cached Version]
  Published on: 10/13/2008    Last Visited: 11/21/2007  

  Williamson, Khan Join Gary Wise on Poker Talk
  ...
  Robert Williamson III, a member of the World Series of Poker (WSOP) Player's Advisory Committee, will be one of Gary Wise's guests on Poker Talk on www.RoundersRadio.com this week.
  ...
  Williamson, one of the world's best Omaha players, will discuss how some of the committee's recommendations played out at the 2007 WSOP and how he sees the committee further influencing the event in the years to come.
  
  He has had numerous top-tier finishes in WSOP Omaha tournaments, including a first-place finish in the 2002 $5,000 Pot Limit event, which earned him $201,160 in prize money.
  
  Williamson, who's also had two money finishes on the World Poker Tour (WPT), has total live tournament winnings of more than $1.8 million.

• 
  dev10.theroom.com.au/company/board.aspx - [Cached Version]
  Published on: 8/8/2008    Last Visited: 8/8/2008  

  Robert Williamson
  ...
  Mr Williamson joined Progen's board as a non-executive director in 2008.Mr Williamson is the founder of LaSalle Venture Advisors, a consultancy serving venture-backed and public life science companies and their investors on strategic and operational issues.He currently serves as a non-executive director of Pharmasset Inc. (NASDAQ:VRUS), an anti-viral therapeutics company.
  
  Prior to founding LaSalle Venture Advisors, Mr Williamson served as President and CEO of Arriva Pharmaceuticals, Inc., and helped the company raise $27 million in venture capital.Previously, Mr Williamson was President and Chief Operating Officer of EOS Biotechnology, Inc., (purchased by PDL BioPharma (NASDAQ:PDLI)).Prior to this, Mr Williamson was President and Chief Operating Officer of DoubleTwist, Inc. (formerly Pangea Systems), a genomics start-up.Mr Williamson began his career at The Boston Consulting Group, Inc., a global business consulting firm, where he was named a Partner, and led the firm's west coast health care practice.
  
  Mr Williamson received a MBA from the Stanford Graduate School of Business in Stanford, CA.He obtained a B.A. in Economics from Pomona College in Claremont, CA.

• 
  www.sec.gov/Archives/edgar/data/1301081/0001193125-08-0 - [Cached Version]
  Published on: 1/25/2008    Last Visited: 1/26/2008  

  The audit committee of our board of directors ("Audit Committee") consists of G. Steven Burrill (Chair), Fredric D. Price and Robert F. Williamson III.
  ...
  The compensation committee of our board of directors ("Compensation Committee") consists of Robert F. Williamson III (Chair), Elliot F. Hahn, G. Steven Burrill and Michael K. Inouye.
  ...
  Robert F. Williamson

• 
  www.24x7mag.com/press_release.asp?id=10192590 - [Cached Version]
  Published on: 3/4/2008    Last Visited: 3/5/2008  

  and Robert Williamson
  
  to the Company's Board as independent non-executive directors following an extensive search as previously announced.
  ...
  -- Mr. Robert Williamson.Independent non-executive director.
  ...
  Mr. Robert Williamson
  
  Mr. Williamson is the founder of LaSalle Venture Advisors, a US-based consultancy serving venture-backed and public life science companies and their investors on strategic and operational issues, including licensing, partnerships, financing and M&A.He currently serves as a non-executive director of Pharmasset Inc. (VRUS), an anti-viral therapeutics company.
  
  From 2004 to 2006, Mr. Williamson
  
  served as President and CEO of Arriva Pharmaceuticals, Inc., a privately-held clinical stage respiratory and dermatological therapeutic company and helped the company raise $27 million in venture capital.Previously, Mr. Williamson
  
  was President and Chief Operating Officer of EOS Biotechnology, Inc., a therapeutic antibody and genomics company, where he was responsible for operations, business development and finances, and was instrumental in the company's sale to Protein Design Labs, now known as PDL BioPharma (PDLI).Prior to this, Mr. Williamson
  
  was President and Chief Operating Officer of DoubleTwist, Inc. (formerly Pangea Systems), a genomics start-up, where he helped the company expand its business model to include genomics content, informatics services and software.Mr. Williamson
  
  began his career at The Boston Consulting Group, Inc., a global business consulting firm, where he was named a Partner, and led the firm's west coast health care practice.

• 
  www.pharmasset.com/bios/BD-williamson.asp - [Cached Version]
  Published on: 3/10/2007    Last Visited: 3/10/2007  

  Robert F. Williamson III
  
  Robert F. Williamson III has served as a member of our board of directors since August 2004.Mr. Williamson is currently a consultant to life sciences companies.Mr. Williamson was the Chief Executive Officer and a director of Arriva Pharmaceuticals from April 2004 to May 2006.He is also the founder of LaSalle Venture Advisors, a consulting firm, where he has served as a consultant since 2002.From 2002 until 2004, Mr. Williamson served as the President and Chief Operating Officer of Eos Biotechnology.Mr. Williamson also served as the President and Chief Operating Officer of DoubleTwist, Inc., a provider of genomic information and bioinformatics analysis technologies, from July 1999 until February 2002(1).Mr. Williamson was also a partner with the Boston Consulting Group, Inc. from 1991 through 1999, where his clients included top global pharmaceutical and medical device companies.Mr. Williamson received a B.A. in Economics from Pomona College and an M.B.A. from the Stanford Graduate School of Business.

Page:  1 2 3 4 5